178 related articles for article (PubMed ID: 3432553)
1. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils.
Spinnewyn B; Blavet N; Clostre F; Bazan N; Braquet P
Prostaglandins; 1987 Sep; 34(3):337-49. PubMed ID: 3432553
[TBL] [Abstract][Full Text] [Related]
2. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat.
Liu XH; Eun BL; Silverstein FS; Barks JD
Pediatr Res; 1996 Dec; 40(6):797-803. PubMed ID: 8947953
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid metabolism and cerebral blood flow in the normal, ischemic, and reperfused gerbil brain. Inhibition of ischemia-reperfusion-induced cerebral injury by a platelet-activating factor antagonist (BN 52021).
Panetta T; Marcheselli VL; Braquet P; Bazan NG
Ann N Y Acad Sci; 1989; 559():340-51. PubMed ID: 2774404
[TBL] [Abstract][Full Text] [Related]
4. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo.
Prehn JH; Krieglstein J
J Neurosci Res; 1993 Feb; 34(2):179-88. PubMed ID: 8095559
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
7. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Braquet P
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
[No Abstract] [Full Text] [Related]
8. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury.
Panetta T; Marcheselli VL; Braquet P; Spinnewyn B; Bazan NG
Biochem Biophys Res Commun; 1987 Dec; 149(2):580-7. PubMed ID: 2827647
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L
Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421
[TBL] [Abstract][Full Text] [Related]
11. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P
Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659
[TBL] [Abstract][Full Text] [Related]
12. The effect of a platelet activating factor antagonist (BN 52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia.
Hofer RE; Christopherson TJ; Scheithauer BW; Milde JH; Lanier WL
Anesthesiology; 1993 Aug; 79(2):347-53. PubMed ID: 8342844
[TBL] [Abstract][Full Text] [Related]
13. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
Berti F; Omini C; Rossoni G; Braquet P
Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
Touvay C; Etienne A; Braquet P
Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
[TBL] [Abstract][Full Text] [Related]
15. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
Smith PF; Maclennan K; Darlington CL
J Ethnopharmacol; 1996 Mar; 50(3):131-9. PubMed ID: 8691847
[TBL] [Abstract][Full Text] [Related]
16. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents.
Braquet P; Hosford D
J Ethnopharmacol; 1991 Apr; 32(1-3):135-9. PubMed ID: 1881152
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
Vilain B; Lagente V; Touvay C; Desquand S; Randon J; Lefort J; Braquet P; Vargaftig BB
Pharmacol Res Commun; 1986 Aug; 18 Suppl():119-26. PubMed ID: 3774840
[TBL] [Abstract][Full Text] [Related]
18. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig.
Bourgain RH; Maes L; Andries R; Braquet P
Prostaglandins; 1986 Jul; 32(1):142-4. PubMed ID: 3763943
[TBL] [Abstract][Full Text] [Related]
19. The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021.
Braquet P; Guinot P; Touvay C
Agents Actions Suppl; 1987; 21():97-117. PubMed ID: 3314418
[No Abstract] [Full Text] [Related]
20. Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.
Parnham MJ; Bittner C; Lambrecht G
Br J Pharmacol; 1989 Oct; 98(2):574-80. PubMed ID: 2819335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
